The world’s leading eCOA solution just got a boost: Signant's flagship TrialMax® platform now leverages intelligent automation and operational enhancements to accelerate study builds by 33% or more, even for the most complex protocols.
Innovative technology automation tools condense study build and testing processes from weeks into days without risk of errors. The result is 33% faster study launches, even for the most complex studies.
Discover how these latest enhancements accelerate eCOA study delivery without compromising quality and functionality.
Our instrument library already includes hundreds of pre-validated, commonly used study scales and translations. When additional scales or translations are needed, our new automation tools accelerate scale management including translations and validation.
Learn more about the industry's most robust, customizable eCOA platform, TrialMax, now delivering faster study launches for even the most complex trial designs.
Additional, forthcoming efficiency enhancements will accelerate post-implementation support for reporting, analytics, and data change management.
As always, TrialMax is delivered with the unrivaled scientific expertise, global operational reach, and comprehensive, attentive services customers have come to expect for nearly 25 years.